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Abstract 43 
Salmonella enterica serotype Kentucky (S. Kentucky) can be a common causative 44 
agent of salmonellosis, usually associated with consumption of contaminated poultry. 45 
Antimicrobial resistance (AMR) to multiple drugs, including ciprofloxacin, is an emerging 46 
problem within this serotype. We used whole-genome sequencing (WGS) to investigate the 47 
phylogenetic structure and AMR content of 121 S. Kentucky ST198 isolates from five 48 
continents (97 sequenced in this study and 24 from the GenomeTrackr project). Population 49 
structure was inferred using phylogenomic analysis and whole genomes were compared to 50 
investigate changes in gene content, with a focus on acquired AMR genes. Our analysis 51 
showed that multidrug resistant (MDR) S. Kentucky isolates belonged to a single lineage, 52 
which we estimate emerged circa 1989 following the acquisition of the AMR-associated 53 
Salmonella genomic island 1 (variant SGI1-K) conferring resistance to ampicillin, 54 
streptomycin, gentamicin, sulfamethoxazole, and tetracycline. Phylogeographic analysis 55 
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indicates this clone emerged in Egypt before disseminating into Northern, Southern and 56 
Western Africa, then to the Middle East, Asia and the European Union. The MDR clone has 57 
since accumulated various substitution mutations in the quinolone resistance determining 58 
regions (QRDR) of DNA gyrase (gyrA) and DNA topoisomerase IV (parC), such that most 59 
strains carry three QRDR mutations which together confer resistance to ciprofloxacin. The 60 
majority of AMR genes in the S. Kentucky genomes were carried either on plasmids or SGI 61 
structures. Remarkably, each genome of the MDR clone carried a different SGI1-K 62 
derivative structure; this variation could be attributed to IS26-mediated insertions and 63 
deletions, which appear to have hampered previous attempts to trace the clone’s evolution 64 
using sub-WGS resolution approaches. Several different AMR plasmids were also identified, 65 
encoding resistance to chloramphenicol, third-generation cephalosporins, carbapenems, 66 
and/or azithromycin. These results indicate that most MDR S. Kentucky circulating globally 67 
result from the clonal expansion of a single lineage that acquired chromosomal AMR genes 68 
30 years ago, and has continued to diversify and accumulate additional resistances to last-line 69 
oral antimicrobials.  70 
Impact Statement 71 
Fluoroquinolone resistant Salmonella enterica and carbapenem resistant, extended 72 
spectrum beta-lactamase (ESBL) producing Enterobacteriaceae are amongst the highest 73 
priority pathogens posing a risk to human health as determined by the World Health 74 
Organisation (WHO). All of these high level resistances have been detected in a single 75 
serotype of S. enterica, S. Kentucky, against a background of multidrug resistance to first-line 76 
antimicrobials, leaving very limited treatment options. Here, we analysed the genomes of S. 77 
Kentucky from geographically diverse sources, to investigate the emergence and spread of 78 
antibiotic resistance in this problem pathogen. We discovered that the multidrug resistant 79 
(MDR) genomes in our collection comprised a clonal MDR lineage that we estimate arose in 80 
Egypt in ~1989, before spreading across Africa, then into Europe, the Middle East and Asia. 81 
Resistance to first-line antibiotics mostly arose from the chromosomal integration of a large 82 
genomic island, the Salmonella Genomic Island 1 (SGI1), in the common ancestor of the 83 
MDR lineage. Most strains were also fluoroquinolone resistant, due to acquisition of point 84 
mutations in chromosomal genes gyrA and parC early in the clone’s evolution. Additional 85 
resistances, including to third-generation cephalosporins (such as ceftriaxone), carbapenems 86 
(such as imipenem), and the last-line oral antibiotic azithromycin, emerged through 87 
acquisition of diverse locally circulating MDR plasmids. Aside from antibiotic resistance, we 88 
found no other genetic determinants that could explain the global success of this S. Kentucky 89 
lineage. These data show the MDR clone of S. Kentucky is already widespread and is capable 90 
of acquiring last-line resistances, suggesting it should be considered a high-risk global MDR 91 
clone.  92 
 93 
Data Summary 94 
All sequencing reads generated in this study have been deposited in project 95 
PRJNA445436. SRA accession numbers can be found in Supplementary Table 1. 96 
 97 
The reference genome sequence for S. Kentucky strain 201001922 has been deposited 98 
into GenBank under accession CP028357. 99 
 100 
The phylogeny and associated metadata can be viewed on Microreact: 101 
https://microreact.org/project/Hkl7CzEXV 102 
 103 
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the article or through supplementary data files.  105 
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Introduction 106 
Carbapenem-resistant, extended-spectrum beta-lactamase (ESBL)-producing 107 
Enterobacteriaceae and fluoroquinolone-resistant Salmonella have been recently listed as 108 
priority pathogens that pose the greatest threats to human health (critical and high threat 109 
levels, respectively) by the World Health Organisation (WHO) (1). All these resistances have 110 
been observed in a single serotype of Salmonella enterica, Kentucky (S. Kentucky), since the 111 
2000s (1-4). Ciprofloxacin-resistant S. Kentucky (CIP
R
 S. Kentucky) was first observed in a 112 
French traveller returning from Egypt in 2002, before being increasingly isolated globally 113 
(1). Between 2007 and 2012, the European Centers for Disease Control and Prevention 114 
(ECDC) reported 1301 isolations of S. Kentucky from 12 countries, including 955 (73.4%) 115 
CIP
R
 S. Kentucky (5). These isolates were found in patients across the world, but 116 
predominantly in Northern Africa, Europe, and Southern Asia. Several previous studies have 117 
described the rapid spread of CIP
R
 S. Kentucky from Northern Africa to the rest of the 118 
African continent, as well as the Middle East, Europe and Asia (2-4). CIP
R
 S. Kentucky is a 119 
foodborne pathogen that causes gastroenteritis in humans, and domestic poultry has played an 120 
important role in its global spread (most recently in South Asia and Europe). Multi-locus 121 
sequencing typing (MLST) and pulsed-field gel electrophoresis (PFGE) have revealed that 122 
CIP
R
 S. Kentucky is a single population belonging to sequence type (ST) 198 and not ST152, 123 
which is a prevalent S. Kentucky ST found in poultry in the United States of America (USA) 124 
but rarely reported in humans (7).  125 
 126 
Before the 1990s, S. Kentucky ST198 was susceptible to all antibiotics. Since then, 127 
multidrug resistance has emerged (1). In the early 1990s, S. Kentucky ST198 acquired a 128 
variant of the Salmonella genomic island 1 (SGI1) into the chromosome, likely in Egypt (6). 129 
Initially characterised in S. enterica serotype Typhimurium strain DT104 (7), the SGI1 is a 130 
site-specific Integrative Mobilizable Element (IME) that integrates in the 3’-end of the 131 
conserved chromosomal gene trmE (8). SGI1 is the prototype element of a multidrug 132 
resistance IME family named SGI/PGI/AGI which includes both Proteus genomic islands 133 
(PGI) (9) and Acinetobacter genomic islands (AGI) (12). They consist of a 27 kbp related 134 
backbone with conserved gene synteny and variable regions containing complex class 1 135 
integron structures, IS, and Tn elements that are responsible for multidrug resistance. As an 136 
IME, SGI1 is specifically mobilized in trans by conjugative IncC plasmids (10-12). The most 137 
recent findings revealed complex interactions between SGI1 and IncC plasmids for transfer 138 
and maintenance. Since the first description of SGI1 in S. Typhimurium DT104, several 139 
variants of SGI/PGI/AGI have been discovered, which differ in their antimicrobial resistance 140 
(AMR) gene content and AMR gene cluster structure (13,14) in species of families 141 
Enterobacteriaceae, Morganellaceae,  and Acinetobacter baumanii (12,18). These variants 142 
usually differ in the composition of the integron, and each variant carries different AMR 143 
genes. One variant of the SGI, known as SGI2 or SGI1-J, differs not only in the composition 144 
of the integron, but also in the site at which the integron is inserted into the SGI backbone 145 
(6,15). 146 
 147 
Four main types of SGI have so far been described in S. Kentucky: SGI1-K, SGI1-P, 148 
SGI1-Q (see Figure 2) and SGI2 (3). These SGI1 variants share a common genetic feature 149 
consisting of an insertion/deletion between S005 and S009 due to the insertion of IS1359, 150 
which was also found in a few other SGI1 variants in strains of different S. enterica serotypes 151 
isolated in 2000 in Egypt, and more recently in P. mirabilis (16). Additionally, these three 152 
SGI1 variants show a truncation the 5’-end of S044, the final ORF of the SGI backbone, 153 
through the insertion of IS26 (17). SGI1-K contains a complex mosaic resistance region 154 
made of different segments of transposons Tn21, Tn1721, Tn5393, Tn3-like, and a In4-type 155 
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integron structure, as well as IS26 elements (18). SGI1-P and SGI1-Q contain only the IS26-156 
flanked Tn3-like structure carrying blaTEM-1 and only the rightmost IS26 in S044, 157 
respectively (17).  158 
 159 
After the acquisition of SGI1 by the multidrug resistant (MDR) lineage, high level-160 
resistance to fluoroquinolones emerged, conferred by a combination of three amino-acid 161 
substitutions in the quinolone resistance-determining region (QRDR) of gyrA and parC. 162 
Previous epidemiological studies determined that these mutations likely arose in Egypt in the 163 
early 2000s (2).  164 
 165 
Finally, additional resistance was gained through the acquisition of locally circulating 166 
plasmid-borne ESBL, AmpC and/or carbapenemase genes (4). Additionally, the geographic 167 
distribution of ciprofloxacin-resistant (CIP
R
) S. Kentucky ST198 overlaps with other highly 168 
drug resistant Enterobacteriaceae carrying plasmid-borne ESBL, AmpC and/or 169 
carbapenemase genes, leading to predictions that highly-drug resistant S. Kentucky ST198 170 
strains are likely to become more frequent in the near future due to novel plasmid 171 
acquisitions (3,4). 172 
 173 
 To date, all previous studies have used conventional typing methods (MLST, PCR, 174 
PFGE, and antimicrobial susceptibility testing (AST)) and together they suggest that the 175 
recent global spread of CIP
R
 S. Kentucky may reflect the expansion of a single clone, driven 176 
by the emergence of AMR. However, the precise nature, order, and timing of the 177 
evolutionary events underlying this overall picture, remain unclear. Here we investigate the 178 
global population structure of MDR S. Kentucky ST198 using whole-genome sequencing 179 
(WGS) and phylogenomic analysis to interrogate a collection of 121 human and non-human 180 
isolates collected from 33 countries on five continents, between 1937 and 2016. We use 181 
comparative genomics to reconstruct the various steps in the acquisition of AMR 182 
determinants within the emerging MDR S. Kentucky ST198 clone, and to investigate the 183 
presence of genetic elements not related to AMR that might have conferred other selective 184 
advantages to this emerging bacterial pathogen. 185 
 186 
Methods 187 
 188 
Bacterial isolates used in this study 189 
A total of 97 S. Kentucky ST198 isolates were directly analysed in this study (Table 190 
S1), including 68 isolates collected between 1937 and 2013 that were previously studied by 191 
conventional molecular methods (2-4,19), and 29 new isolates collected between 2008 and 192 
2016. These isolates originated from the French National Reference Center for E. coli, 193 
Shigella, Salmonella (Institut Pasteur) and several other international laboratories and were 194 
selected on the basis of their diversity (human or non-human source, geographic area and 195 
year of isolation, PFGE types, and antimicrobial resistance phenotypes and genotypes). WGS 196 
data for a further 24 S. Kentucky isolates was included in genomic analyses as detailed 197 
below. 198 
 199 
Antimicrobial susceptibility testing 200 
AST was performed on all 97 S. Kentucky ST198 isolates using the disk diffusion 201 
method with a panel of 32 antimicrobial agents (Bio-Rad, Marnes-La-Coquette, France) as 202 
described previously (24). The minimum inhibitory concentrations (MICs) of ceftriaxone, 203 
ceftazidime, imipenem, ertapenem, meropenem, ciprofloxacin, azithromycin, and tigecycline 204 
were also determined by Etests (AB Biodisk, Solna, Sweden). Results were interpreted with 205 
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the Antibiogram Committee of the French Society for Microbiology/European Committee on 206 
Antimicrobial Susceptibility Testing (CA-SFM/EUCAST) (www.sfm-microbiologie.org/) 207 
breakpoints. In particular, we used ciprofloxacin clinical breakpoints defined for intestinal 208 
Salmonella isolates: susceptible when MIC ≤ 0.25 mg/L and resistant when MIC > 0.5 mg/L. 209 
 210 
Whole-genome sequencing 211 
The 97 S. Kentucky ST198 isolates were subjected to WGS with Illumina at GATC 212 
Biotech (Konstanz, Germany, Illumina HiSeq) (n=45), the Institut Pasteur (PF1 and P2M 213 
sequencing platforms, Illumina HiSeq and NextSeq, respectively) (n=43), the Technical 214 
University of Denmark (n=7, Illumina MiSeq), or at the Institute for Genome Sciences, 215 
University of Maryland School of Medicine (IGS-UoM, Illumina HiSeq) (n=2). Paired-end 216 
reads varied in read length depending on the sequencing platform/site, from 100 to 146 bp, 217 
yielding a mean of 196-fold coverage per isolate (minimum 30-fold, maximum 687-fold) 218 
(Table S1). Short-read sequences have been deposited at the European Nucleotide Archive 219 
(ENA) (http://www.ebi.ac.uk/ena), under study accession number PRJNA445436 and the 220 
genome accession numbers are provided in Table S1.  221 
 222 
Other studied genomes 223 
Additional S. Kentucky ST198 WGS data were obtained from the GenomeTrakr 224 
project (https://ftp-trace.ncbi.nih.gov/pathogen/Results/Salmonella) (20,21). All 3,014 S. 225 
Kentucky isolates in the Salmonella project were downloaded from NCBI on 2016-01-06, 226 
and ST was determined using SRST2 (22). From the 73 available ST198 GenomeTrakr 227 
sequences, we excluded those that were missing the source information required for our 228 
analysis (source, location and year of isolation), and retained those from geographic regions 229 
underrepresented in our own dataset that were non-redundant in terms of source/outbreak 230 
(n=24; accessions in Table S1), bringing the total number of genomes analysed in this study 231 
to 121. 232 
 233 
Sequencing and construction of reference genome 201001922 234 
Genomic DNA from S. Kentucky ST198 isolate 201001922 was also sequenced using 235 
a hybrid sequencing approach at IGS-UoM, as previously described (26). Paired-end, 3-kb 236 
insert libraries sequenced on the 454 GS FLX Titanium platform (Roche, Branford, CT) were 237 
combined with paired-end, 300 to 400-bp insert libraries sequenced with 100-bp read length 238 
on the HiSeq 2000 platform (Illumina, San Diego, CA). Hybrid assemblies were generated 239 
with the Celera assembler (http://wgs-assembler.sourceforge.net/wiki/) based on different 240 
ratios of 454 and Illumina sequence data and the outputs were compared with respect to the 241 
number of resulting scaffolds and total scaffold length. For the final assembly, a 27-fold 242 
genome coverage of 454 and a 30-fold coverage of Illumina sequence data were combined to 243 
create a draft genome sequence consisting of eleven scaffolds and a total length of 4.86 Mbp. 244 
 245 
Contigs and scaffolds from the draft assembly were concatenated using a linker sequence 246 
(NNNNNCACACACTTAATTAATTAAGTGTGTGNNNNN), in order to generate continuous 247 
"pseudochromosomes". The linker sequence contains START and STOP codons in each 248 
frame and orientation, to allow the gene finder to call truncated genes at all contig ends. 249 
Contig orders and orientations within the pseudochromosome were determined based on 250 
NUCmer v3.23 (23) nucleotide sequence comparison to ST152 S. Kentucky strain 251 
CVM29188 (SL475) as a reference genome. Protein-coding and RNA gene predictions and 252 
functional annotations were carried out with CloVR-Microbe (28). 253 
 254 
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The genome sequence of S. Kentucky ST198 isolate 201001922 has been deposited in 255 
GenBank under the accession number CP028357. 256 
 257 
Mapping and phylogenomic analysis 258 
Short reads for all 121 S. Kentucky ST198 isolates were mapped to the reference 259 
genome 201001922 using the mapping pipeline RedDog v1b4 260 
(https://github.com/katholt/RedDog) to identify single nucleotide variants (SNVs) as 261 
previously described (24,25). RedDog uses Bowtie2 v2.2.3 (26) with the sensitive local 262 
method and a maximum insert size of 2000 to map all genomes to the reference genome. 263 
SNVs were then identified using SAMtools v0.0.19 (27) with phred score ≥30, and alleles at 264 
each locus were determined by comparing to the consensus base in that genome, using 265 
SAMtools pileup to remove low quality alleles (phred base quality ≤ 20, read depth ≤5 or a 266 
heterozygous base call). SNVs were filtered to exclude those present in repeat regions, phage 267 
regions, or the SGI. Gubbins v1 (28) was run using default settings to identify and remove 268 
SNVs in recombinant regions. The final SNV set used for phylogenetic analysis consisted of 269 
2,066 SNVs. 270 
 271 
To estimate a Bayesian phylogeny with divergence dates, an alignment of SNV alleles 272 
was passed to BEAST v2.4.6 (29), in addition to isolation dates for each genome. The model 273 
parameters were as follows: GTR+G substitution model, lognormal relaxed clock, constant 274 
population size. As the coefficient of rate variation parameter was calculated to be 0.57 (95% 275 
HPD 0.44-0.70), and the distribution was not abutting zero, a relaxed clock model was 276 
favoured over a strict clock. The model with a constant population size produced higher 277 
overall likelihoods compared to a Bayesian skyline model, and calculations of changes in 278 
population size in the skyline model indicated that the population had been constant over 279 
time, so the simpler model was favoured. Five independent BEAST runs of 100 million 280 
iterations were combined, representing 450 million Markov chain Monte Carlo (MCMC) 281 
generations after burn-in removed. Parameter estimates were calculated using Tracer v1.6 282 
(30). A maximum clade credibility tree was generated using TreeAnnotator v1.7.5 (31). To 283 
test the robustness of the molecular clock signal, ten further BEAST runs with randomised tip 284 
dates were generated using the same model.  285 
 286 
Additional testing of the molecular clock was undertaken by constructing a maximum-287 
likelihood phylogeny using RAxML v8.1.23 (32), using 100 bootstrap replicates, with the 288 
final set of SNVs. To check for a molecular clock signal, a linear regression was performed 289 
using the root-to-tip distances from the phylogeny with year of isolation. 290 
 291 
Phylogeographic analysis was performed by modelling geographic region (defined by 292 
the United Nations subregion geoschemes (33)) as a discrete trait on the final BEAST tree, 293 
using an empirical Bayes method (34) implemented in the make.simmap function in phytools 294 
v0.6.44 (35).  295 
 296 
Assembly, annotation and pangenome analysis 297 
All reads were filtered using FastXToolKit v0.0.14 (36) to remove all reads 298 
containing bases called as ‘N’, and Trimmomatic v0.30 (37) was used to remove any reads 299 
with an average phred quality score below 30. Each isolate genome was assembled using 300 
SPAdes v3.5 (38) using a kmer range of 21, 33, 55, 65 and 75. Scaffolding was performed 301 
using SSPACE v3.0 (39) and GapFiller v1.10 (40) with default settings. All assemblies were 302 
ordered against the S. Kentucky ST198 strain 201001922 reference genome using Abacas 303 
v1.3.1 (41). Prokka v1.10 (42) was used to annotate each assembly using a preferential 304 
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protein database made up of coding sequences from the 201001922 reference genome, the 305 
ARG-Annot resistance database (43), the SGI1, SGI1-K and SGI2 references (accessions 306 
AF261825, AY463797 and AY963803). Roary v3.6.0 (44) was used to determine core and 307 
accessory genes for all annotated genomes. Core genes were defined as present in at least 308 
95% of genomes. 309 
 310 
Identification of resistance, virulence and phage genes 311 
AMR gene alleles were determined by mapping short reads to the ARG-Annot 312 
resistance database (43) using SRST2 (22). AMR gene locations were determined by 313 
interrogating genome assemblies with BLAST v2.3.0 (45). Associations between AMR genes 314 
and SGI type or geographic regions were determined using two-way contingency tables for 315 
each gene. Each region was tested with Fisher’s Exact Test to determine if the frequency of 316 
the gene was positively associated with that specific region compared to all other regions. A 317 
p-value cut-off of 0.05 was used to determine significance. 318 
 319 
Presence or absence of Salmonella virulence genes defined in the VFDB database 320 
(46) was determined using SRST2 to screen the short read data. All genomes were screened 321 
using PHASTER (50) to detect phage regions.  322 
 323 
Reconstruction of SGI sequences 324 
ISMapper v1 (47) and the assembly graph viewer Bandage (48) were used to piece 325 
together segments of the SGI in each genome. To do this, each assembly was queried with 326 
BLAST to identify which contigs contained SGI backbone and AMR genes. Each assembly 327 
was also queried for IS26 using ISMapper's assembly improvement mode (47), identifying 328 
contigs that contained IS26 flanking sequence. Contigs containing flanking IS26 sequence 329 
with SGI genes or AMR genes were hypothesised to be part of the SGI. Both pieces of 330 
information (BLAST and ISMapper results) were used in conjunction with the reference 331 
SGI1-K reference sequence (accession AY463797) to determine which contigs could be 332 
joined together. In some cases, it was unclear whether IS26-flanked AMR genes were located 333 
within the SGI or a plasmid. In these cases, Bandage was used to examine the assembly 334 
graphs and determine the paths linking the SGI, IS26 and AMR genes, providing additional 335 
evidence for contig connection.  336 
 337 
IS26 copy number was estimated by mapping all genomes to the IS26 sequence using 338 
Bowtie v2.2.9 (26), and dividing the read depth across IS26 by the average chromosomal 339 
read depth. To assess whether IS26 copy number was increasing over time within the MDR 340 
lineage, a linear regression analysis was performed using estimated IS26 copy number and 341 
year of isolation for each isolate. 342 
 343 
Analysis of IncI1 and IncC plasmids 344 
All S. Kentucky ST198 genomes were screened for plasmid replicons using SRST2 345 
v0.2.0 with the version of the PlasmidFinder database (49) that is distributed in the SRST2 346 
package. 347 
 348 
Reads from S. Kentucky ST198 isolates containing IncI1 plasmids as well as a set of 349 
publicly available IncI1 plasmid sequences (Table S2) were mapped to the IncI1 plasmid 350 
pNF1358 (accession DQ017661). SNVs were called using the same method as described 351 
above for chromosomal SNVs. The resulting SNVs were filtered to include only those that 352 
were present in core genes (defined as genes present in 100% of the IncI1 plasmid sequences, 353 
see Table S3). The final alignment consisted of 1,380 SNVs, which was used to create a 354 
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maximum likelihood tree with RAxML v8.1.16 (32) using a GTR+G model with 100 355 
bootstraps.  356 
 357 
Reads from S. Kentucky ST198 isolates containing IncC plasmids were typed with 358 
SRST2 against the cgMLST IncA/C plasmid database (50) to determine the 28-locus plasmid 359 
sequence type (pST) for each plasmid. 360 
 361 
Results 362 
 363 
Phylogenetic analysis of S. Kentucky ST198 364 
All 121 S. Kentucky ST198 genomes were mapped to the draft reference genome for 365 
S. Kentucky ST198 strain 201001922 (see Methods), and 2,066 SNVs were identified in the 366 
core genome. Linear regression of root-to-tip distances against year of isolation indicated 367 
strong temporal structure for all isolates, as did date randomisation tests in BEAST (Figure 368 
S1, S2). The alignment of these SNVs and the years of isolation were then used to construct a 369 
dated phylogenetic tree using BEAST, which was further overlaid with region of origin to 370 
infer routes of geographical spread (see Methods). The results (Figure 1) indicate that nearly 371 
all MDR isolates belong to a single monophyletic clade of S. Kentucky ST198, which we 372 
estimate emerged around 1989 (95% HPD 1983 - 1993) in Egypt (Figure 1). The BEAST 373 
analysis estimated the evolutionary rate to be 4.8x10
-7
 substitutions site
-1
 year
-1 
(95% HPD 374 
5.28x10
-7
 - 3.78x10
-7
 substitutions site
-1
 year
-1
; see Figure S2). This is equivalent to a mean 375 
rate of 1.6 SNVs per year, which is similar to rates estimated for other nontyphoidal 376 
Salmonella serotypes including Typhimurium and Agona (51-53), and faster than those 377 
estimated for typhoidal serotypes Typhi and Paratyphi A (54-56). 378 
 379 
The MDR clade includes all isolates carrying SGI1-K and derived variants, which 380 
include all of the CIP
R
 S. Kentucky ST198 (Figure 1; more details below). In addition to the 381 
SGI, the MDR lineage has accumulated amino acid mutations in the QRDR. The first 382 
mutation occurred circa 1992 in gyrA codon 83 (TCC to TTC, Ser83Phe) (light purple, 383 
Figure 1), and was then followed circa 1996 by a mutation in codon 80 of parC (AGC to 384 
ATC, Ser80Ile) (pink, Figure 1). These mutations increased MIC to ciprofloxacin, but CIP
R
 385 
did not arise until additional mutations in codon 87 of gyrA; at least three such mutations 386 
were observed in the MDR clade (GAC to GGC, AAC or TAC; Asp87Gly, Asp87Asn, 387 
Asp87Tyr) (dark purple shades, Figure 1).  388 
 389 
The parC-80 and gyrA-87 mutations accompanied a dramatic clonal expansion, with 390 
the clone spreading from Egypt to other geographical locations (Figure 1). Multiple 391 
independent transfers of S. Kentucky ST198 out of Egypt and Northern Africa are evident, 392 
with two clades, carrying either Asp87Tyr (TAC) or Asp87Asn (AAC) mutations in GyrA 393 
codon 87 emerging circa 2000. The former spread into East Africa, Middle Africa, South 394 
Asia, Europe and Western Asia (dark red line, Figure 1); the latter spread to South-East Asia, 395 
Europe and West Africa (black line, Figure 1). 396 
 397 
Interestingly, the ST198 genomes isolated from agricultural sources in the USA 398 
(including 98K, isolated from poultry in 1937, see Table S1) lack the SGI and gyrA/parC 399 
mutations (Figure 1). Notably, while these strains were isolated contemporaneously with the 400 
MDR clade (2003 to 2016) they are only distantly related to it, sharing a most recent common 401 
ancestor (MRCA) circa 1925 (95% HPD 1898-1938; Figure 1). This finding is consistent 402 
with previous work indicating that ST198 isolates from livestock or poultry in the USA 403 
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belong to a different genomic cluster (198.1) than MDR ST198 isolates from clinical cases 404 
(198.2) (7). 405 
 406 
Long-term persistence in a single patient 407 
Three S. Kentucky ST198 isolates were recovered, in consecutive years (2009, 2010 408 
and 2011) from the same patient who had been infected in Egypt (dark orange box, Figure 409 
1). These isolates belonged to the MDR lineage and shared an MRCA circa 2005, suggesting 410 
persistent colonization of ~6 years duration (Figure 1). The 2011 isolate, 201100664, 411 
differed the most from the inferred MRCA (30 SNVs; 21 non-synonymous SNVs, 6 412 
synonymous SNVs, 3 intergenic SNVs), yielding an estimated in vivo substitution rate of 5 413 
SNVs per year, faster than that estimated by BEAST analysis of the whole data set. Many of 414 
the non-synonymous mutations were in genes responsible for flagella (n=7) and iron 415 
transport (n=2) (Table S4), although no motility changes were detected in this isolate. Eleven 416 
SNVs separated 201000305 and 09-9322 (8 non-synonymous SNVs, 2 synonymous SNVs, 1 417 
intergenic SNV). One of these eleven SNVs was found in another iron transport gene 418 
(asmbl_3909, Table S4). 419 
 420 
SGI in S. Kentucky 421 
The presence of any SGI backbone genes was taken as evidence of SGI integration 422 
(Figure S3). The data indicate that the SGI has been acquired by S. Kentucky ST198 on three 423 
distinct occasions, integrating each time site-specifically in the 3’-end of the trmE gene. SGI2 424 
(previously SGI1-J), which carries the multidrug resistance region in a different position of 425 
the SGI1 backbone (Figure 2a) was present in a single isolate from Indonesia, and SGI1-B 426 
was present in a single isolate from India; both these isolates were distantly related to the 427 
main MDR lineage (Figure 1). The vast majority (95%) of genomes belonging to the main 428 
MDR lineage carried the SGI1-K subtype or one of its derivatives (SGI1-P or SGI1-Q), 429 
consistent with acquisition of SGI1-K in the MRCA circa 1989 in Egypt, shortly before the 430 
expansion of the clone (Figure 1). Within this MDR lineage, some isolates had large 431 
deletions of the SGI backbone (eg: deletions spanning from S011 to S026, or from int to 432 
S026), but still retained the multidrug resistance region between trmE and yidY (Figure S3, 433 
Figure S4). 434 
 435 
Almost every SGI1-positive S. Kentucky ST198 isolate in this study had a distinct 436 
SGI structure (Figure 2b, Figure S4). In addition to large deletions of the SGI backbone, 437 
some isolates had inversions of whole or part of the resistance gene segment of the island, 438 
with various deletions and rearrangements of the transposons (Figure 2b). There were 439 
multiple different IS26 insertion sites within the resistance elements of the island, providing 440 
evidence that IS26 has mediated the majority of differences found in the resistance region of 441 
the island (Figure 2b). We found that IS26 was rarely present in S. Kentucky ST198 isolates 442 
outside of the MDR lineage (Figure S3). Within the MDR lineage, linear regression analysis 443 
of IS26 copy number against year of isolation showed some evidence of IS26 accumulation 444 
over time (0.12 IS26 copies per year, p=0.01, R
2
=0.05) (Figure S5). 445 
There was no relationship between degraded SGI1s and geographic region or country, 446 
or between the loss of core SGI resistance genes (defined as aacA5, blaTEM-1, sul1 and tetA) 447 
and region (see Methods). We found that strAB, aphA2, aph3-Ia, catA1, dfrA12 and 448 
mph(A)were present significantly more frequently in Egypt compared to all other regions 449 
(Table S5). 450 
 451 
Multidrug resistance genes and plasmids in S. Kentucky ST198 452 
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Overall, we found that 35 isolates in the full strain set carried at least one plasmid, 453 
covering 13 different known plasmid incompatibility types (Table S1). Within the MDR 454 
lineage, there was extensive phenotypic and genotypic variation in antimicrobial 455 
susceptibility observed (Figure 3). A part of this variability could be attributed to the 456 
acquisition of plasmids carrying additional AMR genes, as 32 isolates in the MDR lineage 457 
carried genes outside the SGI that are likely plasmid-borne (Figure 3e). Known plasmid 458 
replicons were identified in 23 isolates, and in total we identified eight different plasmid 459 
incompatibility types across the MDR strain set (C, I1, L/M, Q1, W, X1, X4, Y). From these 460 
23 isolates carrying known plasmid incompatibility types, we were able to determine precise 461 
plasmid-AMR gene links for 20 isolates.  462 
 463 
There appeared to be no link between geography and plasmid type, with plasmids 464 
present in isolates from multiple different regions (Figure S6). The majority of genes 465 
encoding carbapenemases (blaOXA-48 and blaNDM-1), ESBLs (blaCTX-M-1) and cephamycinases 466 
(blaCMY-2, blaCMY-4 and blaCMY-16) were carried by either IncI1 or IncC (previously IncA/C2) 467 
plasmids (Figure 3d, 3e). Two IncL/M plasmids were found to carry blaOXA-48 or blaCTX-M-15, 468 
and an IncW plasmid was found to carry blaVIM-2 (Figure 3d, 3e). The eight isolates resistant 469 
to azithromycin contained the mph(A) gene. These isolates clustered into two groups. A 470 
plasmid location of mph(A) was found for four isolates. Three different Inc types were 471 
identified (IncI1, IncC, and IncL/M). 472 
  473 
There was little evidence that any plasmids were being maintained as the MDR 474 
lineage evolved (Figure 3), although the group of three isolates recovered from the same 475 
patient in Egypt (09-9322, 201000305, 201100664; discussed above) all carried IncI1 476 
plasmids. These three plasmids were identical in their core gene content, although IncI1 477 
plasmids in 201100664 differed from those in the earlier two isolates by two intergenic SNVs 478 
(Figure S7). Interestingly these three isolates all lacked the SGI and any other chromosomal 479 
resistance genes, and their IncI1 plasmids differed substantially from one another in 480 
resistance gene content (Figure 3e). The two early isolates mostly carried resistance genes 481 
for aminoglycosides, sulfonamides, trimethoprim, phenicols and macrolides. The plasmid in 482 
the final isolate, 201100664, had lost almost all of the resistance genes found in the previous 483 
two isolates, except for mph(A), and had gained the carbapenemase-encoding blaOXA-48 gene. 484 
IncI1 plasmids were detected in a further six S. Kentucky ST198 genomes, but these did not 485 
cluster in either the IncI1 plasmid tree or the chromosome tree, consistent with seven distinct 486 
introductions of IncI1 plasmids into the S. Kentucky ST198 MDR lineage, each associated 487 
with distinct AMR gene contents (Figure 3, Figure S7). 488 
 489 
Two isolates of the MDR lineage carried IncC plasmids (99-2998 and 201410673). 490 
Both IncC plasmids were genotyped as pST3, which is commonly associated with blaCMY 491 
(50), and this cephamycinase-encoding gene was found in the plasmid from isolate 99-2998. 492 
Interestingly, the IncC plasmid in isolate 201401673 was carrying a carbapenemase-encoding 493 
blaNDM-1 gene, which is more commonly found in pST1 IncC plasmids (50). This blaNDM-1 494 
gene was found in a different structural context to the blaNDM genes in the pST1 IncC 495 
plasmids; as usual it was downstream of ISAba125, however instead of being upstream of 496 
ble, instead it was upstream of qacE1 and sul1, with a remnant of the ble gene left behind 497 
from the insertion of qacE1 (Figure S8). We found that this blaNDM-1 region was entirely 498 
covered by WGS reads, with no breaks or gaps in coverage, supporting that it is the true 499 
structure in this plasmid (Figure S8). This configuration also appears in another pST3 IncC 500 
plasmid, pRH-1238, from S. enterica serotype Corvallis (GenBank accession KR091911), 501 
isolated from a wild bird in Germany (57).  502 
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 503 
Another source for the phenotypic diversity of S. Kentucky ST198 susceptibility 504 
profiles was variations in the SGI1 (Figure 3d). Notably, plasmid carriage was significantly 505 
associated in the cases where SGI1-P, SGI1-Q (containing few or no AMR genes), or no SGI 506 
were detected (Fisher’s Exact Test, p=0.024, OR=2.65 95% CI = 1.09 - 6.64) (Figures 3b, 507 
3d, 3e).  508 
 509 
Chromosomal gene content diversity amongst S. Kentucky ST198 isolates 510 
There was very little gene content diversity evident amongst the S. Kentucky ST198 511 
chromosome sequences (Figure S9). Three phages were detected within the reference 512 
genome 201001922 and these three phage regions, in addition to the SGI1, were the only 513 
regions to show large differences between genomes from the MDR lineage and those from 514 
other lineages (Figure S9). Supporting this, within the accessory gene content identified 515 
using Roary (see Methods), only four genes were found to be present exclusively in all but 516 
one of the MDR lineage genomes. All four of these genes were located within a single phage, 517 
ST160 (43 kbp, 46 genes, positions 541864 - 584944 in the 201001922 reference genome). 518 
This phage was found to be inserted between ompP and mlaA in the MDR lineage. A 519 
variation of this phage was also present in the oldest genome, 98K, which is outside the MDR 520 
lineage, however in this genome the phage was inserted between napB and hutI. 521 
 522 
Examination of the virulence gene content in all isolates revealed that there was no 523 
difference between S. Kentucky ST198 isolates belonging to the MDR lineage and those 524 
belonging to other lineages (Figure S10). Only five virulence genes were present in less than 525 
95% of genomes – gogB (0.8%), sipB (7%), sipC (35%), ompD (57%) and sciQ (80%) 526 
(Table S6) – however these were randomly distributed in the tree and not associated with 527 
lineage (Figure S10).  528 
 529 
Discussion 530 
Our data show that nearly all MDR S. Kentucky ST198 belong to a single lineage that 531 
has accumulated AMR determinants since the early 1990s (Figure 1). It first acquired a 532 
variant of the SGI1, SGI1-K which conferred resistance to ampicillin, streptomycin, 533 
gentamicin, sulfamethoxazole, and tetracycline (Figure 2). The SGI1 structure appears to be 534 
highly susceptible to genetic rearrangements, with distinct forms found in each isolate likely 535 
due to the transpositional activity of IS26, which resulted in deletion of some or all genes 536 
inside SGI1. The loss of resistance genes was often made up for by acquisition of additional 537 
MDR plasmids (Figure 3). 538 
 539 
IS26 is 820 bp long and encodes a single transposase with 14 bp terminal repeats on 540 
each end (58). Each of the three SGI1 subtypes found in the MDR lineage carried one or 541 
more copies of IS26, and all genomes in the MDR lineage carried IS26, with no genomes 542 
outside of this clade carrying IS26. The recently described mechanism used by IS26 to 543 
transpose may provide an explanation as to why the SGI variants in these isolates are so 544 
dynamic. During the transposition, IS26 extracts itself from the donor DNA molecule, as well 545 
as DNA lying upstream of it between itself and another IS26 element, and uses this to form a 546 
translocatable unit (59). It then finds another IS26 element in the receiving DNA molecule, 547 
and inserts itself as well as the excised donor DNA next to it, forming a tandem array of 548 
IS26s in direct orientation (59). This model illustrates that IS26 is likely the causative agent 549 
for many of the deletions, inversions and transpositions within the SGI, eventually resulting 550 
in the genesis of the different SGI1 variants (SGI1-K, SGI1-P and SGI1-Q) seen in this 551 
dataset (Figure 2).  552 
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 553 
Whilst the origin of the MDR clade appears to be intimately linked with the acquisition of the 554 
SGI1 in Egypt, it is the QRDR triple-mutant CIP
R
 subclade that disseminated globally 555 
(Figure 1). Ciprofloxacin resistance is infrequent in Salmonella (64), and we hypothesise that 556 
this high-level resistance is linked to strong selective pressure exerted by fluoroquinolone use 557 
in poultry, S. Kentucky’s main reservoir (65). This resistance might also have come at no cost 558 
to the fitness of the bacterial cell, as has been shown in close relatives S. Typhi and 559 
Escherichia coli (60,61).  560 
 561 
During its spread around the world, the S. Kentucky ST198 MDR lineage became 562 
more resistant by the additional acquisition of various AMR plasmids, carrying genes 563 
encoding resistance to newer drugs including third-generation cephalosporins, carbapenems 564 
and azithromycin. These genes were acquired locally around the Mediterranean basin with no 565 
subsequent clonal expansion. Interestingly, the two isolates containing IncC plasmids did not 566 
carry the SGI. This observation is supported by many studies in the literature which have 567 
described the incompatibility of the SGI and IncC plasmids, as they share the same regulatory 568 
system (11,62,63). 569 
 570 
In this study we were unable to detect any other non-AMR related genes that could 571 
explain the clonal success of the MDR lineage. Examination of phage, pseudogenes and 572 
known virulence genes did not reveal any significant differences between the MDR lineage 573 
and other S. Kentucky ST198 genomes, although this does not rule out the possibility of more 574 
subtle variants contributing to virulence such as the regulatory SNV recently described for 575 
invasive S. Typhimurium ST313 (70). 576 
 577 
In conclusion, WGS analysis of S. Kentucky ST198 has significantly expanded our 578 
knowledge of the evolution and dissemination of MDR variants of this important pathogen. 579 
Previously, as this lineage was emerging, MLST and PFGE were used in combination (1,2) 580 
for this purpose; however the diversity of PFGE types of CIP
R
 S. Kentucky ST198 isolates 581 
precluded any fine-scale or long-term analysis of S. Kentucky ST198 dissemination, which 582 
our data shows was likely due to noise introduced by IS26 activity. The population structure 583 
uncovered here should serve as a useful framework with which to understand and track the 584 
ongoing evolution of the MDR lineage of S. Kentucky ST198, which our data clarifies is a 585 
globally disseminated clone capable of rapid spread and further accumulation of last-line 586 
AMR determinants. 587 
 588 
 589 
  590 
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Figures and Tables 856 
Figure 1: Phylogeographic analysis of S. Kentucky ST198 based on whole genome SNV 857 
data. Bayesian maximum clade credibility tree inferred using BEAST, with MDR lineage 858 
shaded orange. Dark orange box indicates three isolates from the same patient. Major internal 859 
nodes are labeled with circles indicating branch support (black, ≥95% posterior support; red, 860 
>70% posterior support; hollow, >30% posterior support); divergence date estimates (95% 861 
higher posterior density values) are provided for key points in the evolution of the MDR 862 
lineage. Leaf nodes are coloured by region of origin (see inset map). Coloured branches 863 
indicate inferred geographical distribution of internal branches, inferred using maximum 864 
likelihood ancestral trait reconstruction. Data columns indicate country of origin; source of 865 
isolate (H for human, N for non-human, ? for unknown); SGI type (see inset legend); 866 
quinolone resistance-related codons, with resistance-associated alleles highlighted. Reference 867 
genome 201001922 is marked with red arrow. Red and black vertical lines indicate clades 868 
that are mentioned in-text. 869 
 870 
 871 
Figure 2: SGI variation in S. Kentucky ST198. a, Backbone of SGI, with arrows pointing 872 
to the different insertion sites of the resistance region in SGI1 and SGI2. b, Different 873 
examples of SGI1 types in S. Kentucky ST198. Arrows show open reading frames (ORF) of 874 
the SGI backbone and MDR region with arrowheads indicating direction of transcription; 875 
colour indicates gene class. Coloured blocks indicate regions of homology between 876 
sequences in the same orientation; green, same orientation; orange, inverse orientation. 877 
 878 
 879 
Figure 3: Horizontally acquired antimicrobial resistance genes in the S. Kentucky 880 
ST198 MDR lineage. a, Dated Bayesian (BEAST) phylogeny for the MDR lineage, 881 
extracted from the tree shown in Figure 1. Leaf nodes are coloured by region of origin (see 882 
legend); orange box highlights three isolates recovered from the same patient over three 883 
years. b-e shows AMR features of each isolate in the tree. b, SGI type (see legend, dash 884 
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indicates no SGI detected). c, AMR phenotypes, indicated as boxes coloured by antimicrobial 885 
class (see legend, I in box denotes intermediate resistance). d, AMR genes located within the 886 
SGI1 are indicated with boxes coloured by antimicrobial class (* in box indicates gene is 887 
interrupted). e, plasmid incompatibility group(s) identified in each genome; antimicrobial 888 
resistance genes located within these plasmids are printed, coloured by antimicrobial class; 889 
genes in brackets are genes whose location was unable to be determined. 890 
 891 
 892 
Supplementary Figure 1: Temporal signal in the maximum likelihood phylogeny. Grey 893 
dots, isolates not within the MDR lineage; red dots, isolates within the MDR lineage. Grey 894 
line, linear regression of all isolates in tree; red line, linear regression of only isolates within 895 
the MDR lineage. Values reported are the correlation coefficients for these regressions. 896 
 897 
 898 
Supplementary Figure 2: Mutation rate estimates for real and randomised tip dates in 899 
S. Kentucky ST198. First column, real mutation rate, in substitutions per site per year. 900 
Subsequent columns show mutation rate when tip dates are randomised. Black circles are the 901 
mean rate estimated by BEAST, with error bars showing 95% highest posterior density 902 
(HPD). 903 
 904 
 905 
Supplementary Figure 3: Presence of SGI backbone genes in each S. Kentucky ST198 906 
isolate, with an estimate of overall IS26 copy number. Left, dated Bayesian phylogeny, 907 
with tips and branches coloured by region (as per map inset and Figure 1). Red blocks 908 
indicate the presence at least one resistance gene in the SGI resistance region. Light blue 909 
blocks indicate presence of chromosomal genes flanking the SGI (trmE and yidY). Dark blue 910 
blocks indicate presence of SGI backbone genes. Yellow bars show estimated IS26 copy 911 
number in each isolate. 912 
 913 
 914 
Supplementary Figure 4: Additional SGI1 examples. Coding regions are represented as 915 
arrows and are coloured as per legend. SGI sequences are grouped by type - SGI1-K, SGI1-P 916 
and SGI1-Q. Contig breaks are shown by thick black vertical lines, with IS26 flanking 917 
regions detected with ISMapper marked with purple vertical lines. 918 
 919 
 920 
Supplementary Figure 5: Relationship between year of isolation of S. Kentucky ST198 921 
and estimated IS26 copy number. Points are coloured by the SGI type found in that strain, 922 
as per legend. 923 
 924 
 925 
Supplementary Figure 6: Heatmap showing proportion of each plasmid replicon within 926 
each region found in the S. Kentucky ST198 MDR lineage. 927 
 928 
 929 
Supplementary Figure 7: Maximum-likelihood phylogeny of IncI1 plasmids. Phylogeny 930 
is midpoint rooted, with tips coloured by genus (as per legend) and S. Kentucky ST198 931 
isolates from this study coloured pink. Orange box indicates three S. Kentucky isolates from 932 
a single patient, all carrying IncI1 plasmids. Country of isolation is listed next to the S. 933 
Kentucky isolates used in this study. 934 
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 935 
 936 
Supplementary Figure 8: Coverage across NDM-1 region in isolate #201410673. 937 
Positions of genes depicted as arrows, with arrows pointing in the direction of transcription. 938 
Light blue, other plasmid genes; red, resistance genes; purple, transposable elements. Genes 939 
without names are hypothetical proteins. Dark orange box shows boundaries of exact match 940 
to the same blaNDM-1 configuration in S. enterica serotype Corvallis (GenBank accession no. 941 
KR091911). Depth is number of reads at each base position on the x-axis.  942 
 943 
 944 
Supplementary Figure 9: Comparison of a subset of S. Kentucky ST198 genomes to 945 
reference genome 201001922. Inner black ring indicates 201001922 genome position, 946 
followed by GC content. Blue rings indicate S. Kentucky ST198 isolates belonging to the 947 
MDR lineage, grey rings other S. Kentucky ST198 isolates. The location of each isolate is 948 
shown on the phylogeny - numbers indicate which ring is shown by the isolate. 949 
 950 
 951 
Supplementary Figure 10: Heatmap of virulence gene content in all S. Kentucky ST198 952 
isolates. Tips of the phylogeny are coloured by region, as per legend. Each column of the 953 
heatmap is a virulence gene, black indicates presence, white indicates absence. Virulence 954 
genes are clustered to reveal patterns.  955 
 956 
Supplementary Table 1: Metadata associated with each S. Kentucky ST198 isolate used 957 
in this study. 958 
 959 
Supplementary Table 2: Plasmid accessions for IncI1 plasmids used in this study. 960 
 961 
Supplementary Table 3: Genes defined as core in the reference IncI1 plasmid pNF1358 962 
in this study. 963 
 964 
Supplementary Table 4: Mutations found amongst the three isolates taken from the 965 
same patient. 966 
 967 
Supplementary Table 5: P-values (calculated using Fisher’s Exact Test) between 968 
resistance genes and geographic regions for each resistance gene found across all 969 
isolates. P-values < 0.05 indicate a positive association with that resistance gene and that 970 
specific geographic region. 971 
 972 
Supplementary Table 6: Presence or absence of virulence genes from VFDB in each 973 
isolate. 974 
 975 
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